Pharmaceutical business in Tajikistan is at the development stage, with a focus on importing medicines and gradually increasing local production. Our website provides articles on the structure of the industry, key market players and the specifics of pharmaceutical regulation in the country.
Explore the support measures taken by the government to stimulate domestic drug production, including tax incentives and investment projects. Highlight the challenges facing the sector, such as dependence on imports and the need to improve product quality. Gain an understanding of the opportunities for improving health care and developing Tajikistan’s economy through integration into regional and global pharmaceutical networks.
Tajikistan, a country nestled in the heart of Central Asia, is home to a population of approximately 10.3 million people as of early 2024.
The Complex Ascent of Tajikistan’s Dominant Pharmaceutical Enterprise Read More »
